A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Conditions:   Uterine Fibroids;   Endometriosis Intervention:   Drug: Relugolix Combination Tablet Sponsor:   Myovant Sciences GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials